Genetic analysis of nearly 700,000 people identified 74 distinct sites in the human genome associated with anxiety, 39 of which had not been linked to the condition before.
Genetic analysis has identified nearly 700,000 people 74 regions of the human genome associated with anxiety symptomsincluded 39 that were not previously associated with this conditionGiving scientists the most detailed picture yet of the biology of one of the world’s most common mental health disorders.The international study published in The nature of human behaviorLed by researchers from King’s College London and the Australian QIMR Berghofer Institute for Medical Research. He analyzed the genetic information from 693,869 people of European originMaking it the largest genome-wide association study (GWAS) ever conducted on anxiety.The researchers say the unprecedented scale of the study enabled them to detect genetic signals that smaller investigations had missed.
Rather than uncovering a single “anxiety gene,” they identified dozens of small genetic variations that together influence a person’s susceptibility to anxiety.
The largest genetic study of anxiety to date
Although anxiety disorders affect hundreds of millions of people worldwide, scientists know less about their genetic basis than other psychiatric conditions such as depression and schizophrenia.The new research nearly doubled the size of previous GWAS studies of anxiety, allowing researchers to uncover many more genetic links simply because the data set was much larger.
Genome-wide association studies scan the DNA of hundreds of thousands of people to determine which genetic variations occur more frequently in people with a particular trait or condition. Because mental disorders are influenced by many genes, each of which has a very small effect, researchers need enormous data sets before these signals can become statistically reliable.The result is the most comprehensive genetic map of anxiety produced to date.“Despite anxiety’s overall health impact, progress in understanding genetics lags behind other major mental health conditions.”Professor Thalia Eley from King’s College London, senior author of the study, said anxiety had received much less attention in genetic research despite being the most common category of mental illness worldwide.
Look at symptoms rather than diagnosis
One reason this study revealed more genetic regions than previous research lies in how anxiety is measured.Instead of dividing participants into those with and without a diagnosed anxiety disorder, the researchers measured Severity of anxiety symptoms Across the entire population. This allowed them to include people with everything from everyday anxiety to severe clinical symptoms.Researchers say many people suffer from significant anxiety without receiving a formal diagnosis. By treating anxiety as a continuous spectrum rather than a simple yes or no diagnosis, they retained much more genetic information.This decision seems to have paid off. Previous diagnostic-based studies have identified approximately thirty genetic regions associated with anxiety. This study found 74.
Key genes associated with brain activity
Among the strongest results were two genes, PCLO and Sorex3Both have been previously associated with other psychiatric disorders.These genes help regulate communication between neurons at synapses, where brain cells exchange signals. Many of the newly identified genetic regions are also located near genes that are highly active in brain tissue.These findings reinforce the idea that anxiety is not caused by a single faulty gene. Instead, hundreds of small genetic influences appear to work together alongside environmental factors such as stress, trauma, and life experiences.In other words, there is no single genetic switch to anxiety. Each variable contributes only a small increase in risk.
Genetics shared with physical diseases
Researchers also discovered significant genetic overlap between anxiety and several physical health conditions, including Heart disease, migraines, and gastrointestinal disorders.They stress that this does not mean that anxiety causes these diseases, or vice versa. Instead, some of the same genetic variations appear to increase the likelihood of anxiety and some physical conditions.Doctors have long noted that people with anxiety often suffer from migraines, cardiovascular symptoms, or conditions such as irritable bowel syndrome. The study provides new biological evidence that may help explain why these conditions often occur together.Scientists believe that these shared genetic pathways could become an important focus of future research.
What the results actually mean
While the study represents a major advance, the researchers caution against overestimating its immediate clinical impact.Only common genetic variations are explained 6 percent Differences in anxiety symptom severity across populations. Polygenic risk scores generated using the new data represent up to 2.9 percent of this difference individually.This means that the results are valuable for understanding the biology of anxiety, but they cannot accurately predict whether a particular individual will develop the condition.Researchers emphasize that environment, childhood experiences, trauma, stress, and other life factors continue to play a much larger role in determining a person’s mental health.The study does not pave the way for a genetic test that can reliably predict anxiety.
Instead, it provides scientists with a clearer road map for understanding the biological processes involved.
An increasing global burden
These findings come as anxiety disorders continue to affect a growing number of people around the world.Researchers appreciate this 359 million people Were living with anxiety disorders in 2021, around 4.4% of the world’s population. It is expected to exceed this number 515 million by 2040with cases rising faster than population growth alone.Despite its widespread impact, treatment is still not available to many people. In many high-income countries, fewer than one in three people with an anxiety disorder receive treatment, while access to it is more limited in low-income countries.Even when treatment is available, it is not suitable for everyone.Most medications currently prescribed for anxiety, including selective serotonin reuptake inhibitors (SSRIs), were developed decades ago.
Psychological treatments such as cognitive behavioral therapy have helped many patients, but a large number of them continue to suffer from symptoms despite treatment.Researchers say this reflects how little is understood about the biology behind anxiety.
A roadmap for future treatments
Newly identified genetic regions could help change that.Instead of relying largely on trial and error to develop drugs, scientists now have dozens of biological targets to investigate.Many of the identified genes are involved in communication between brain cells, providing potential pathways for developing treatments that target the biology of anxiety rather than simply reducing symptoms.The researchers warn that this discovery will not immediately lead to the production of new medicines. The next phase will involve laboratory research to understand what these genes actually do inside brain cells, followed by animal studies and eventually clinical trials if promising targets emerge.Some newly identified regions have not been linked Ha before concern, which opens entirely new directions for research.
The next chapter in the genetics of anxiety
The researchers say that the study represents an important starting point, not the end of the journey.Future studies including larger and more diverse populations will be needed, as current research only includes people of European descent. Scientists also expect that larger international datasets will reveal additional genetic regions associated with anxiety.For now, the study provides something that anxiety research has lacked for decades: a detailed genetic map.Rather than claiming that the anxiety has finally been explained, the results are presented to the researchers 74 new sites in the human genome to investigateincluded 39 that were not previously associated with this conditionproviding new evidence into the biology of anxiety and new ways to develop better treatments.
